SEC Form D · filed March 25, 2019
Apexian Pharmaceuticals, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (24)
Timothy R. Tichenor · Indianapolis, INExecJohn R. Barnard · Indianapolis, INDirectorMark R. Kelley, Phd · Indianapolis, INDirectorMartin R. Haslanger, Phd · Indianapolis, INDirectorRoger R. Miller · Indianapolis, INExecDavid R. Broecker · Indianapolis, INExec · DirectorRichard R. Messmann · Indianapolis, INExecHomer R. Pearce, Phd · Indianapolis, INDirectorClayton Moore · Vancouver, British Columbia, CanadaExecChristopher P. Cherry · Vancouver, British Columbia, CanadaDirectorNikita B. Sangani · DALLAS, TXExecFelicia P. Logan · Stockbridge, GAExec · DirectorBharat H. Sangani · DALLAS, TXExecDavid B. Rose · Winston-Salem, NCDirectorJeffrey C. Ackerman · Winston-Salem, NCDirectorStuart U. Mitchell Jr · Stockbridge, GADirectorGlenn Davis · Glenwood Springs, COExecRobert Young · Glenwood Springs, CODirectorKris Gardner · Glenwood Springs, CODirectorSteve N. Parker · Glenwood Springs, CODirectorGlen Jammaron · Glenwood Springs, COExecNorm Franke · Glenwood Springs, COExec · DirectorTerry Farina · Glenwood Springs, COExecTom N. Kenning · Glenwood Springs, CODirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗